Evidence map›Paper›PMID 28554943›Full record

ArticleEMBO molecular medicine2017

SPINK2 deficiency causes infertility by inducing sperm defects in heterozygotes and azoospermia in homozygotes.

Zine-Eddine Kherraf, Marie Christou-Kent, Thomas Karaouzene, Amir Amiri-Yekta, Guillaume Martinez, Alexandra S Vargas, Emeline Lambert, Christelle Borel, Béatrice Dorphin, Isabelle Aknin-Seifer and 16 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Extraction, purification, biological effects and applications of acrosin: a review.Frontiers in cellular and infection microbiology · 2025
    Review
  11. ECRG2/SPINK7 Tumor Suppressor as Modulator of DNA Damage Response.International journal of molecular sciences · 2024
    Review
  12. Review
  13. Effects ofHuman reproduction open · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Upregulation of SPINK2 in acute myeloid leukemia.Advances in laboratory medicine · 2023
    Review
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 3 countries.

Zine-Eddine KherrafGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Marie Christou-KentGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Thomas KaraouzeneGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Amir Amiri-YektaGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Guillaume MartinezGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Alexandra S VargasGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Emeline LambertGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Christelle BorelDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva 4, Switzerland.
Béatrice DorphinLaboratoire d'Aide Médicale à la Procréation, Centre AMP 74, Contamine-sur-Arve, France.
Isabelle Aknin-SeiferLaboratoire de Biologie de la Reproduction, Hôpital Nord, Saint Etienne, France.
Michael J MitchellAix Marseille Univ INSERM GMGF, Marseille, France.
Catherine Metzler-GuillemainAix Marseille Univ INSERM GMGF, Marseille, France.
Jessica EscoffierGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Serge NefDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva 4, Switzerland.
Mariane GrepillatGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Nicolas Thierry-MiegUniv. Grenoble Alpes / CNRS, TIMC-IMAG, Grenoble, France.
Véronique SatreGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Marc BaillyDepartment of Reproductive Biology and Gynaecology, Poissy General Hospital, Poissy, France.
Florence BoitrelleDepartment of Reproductive Biology and Gynaecology, Poissy General Hospital, Poissy, France.
Karin Pernet-GallayGrenoble Neuroscience Institute, INSERM 1216, Grenoble, France.
Sylviane HennebicqGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Julien FauréCHU de Grenoble, UF de Biochimie Génétique et Moléculaire, Grenoble, France.
Serge P BottariGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Charles CouttonGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Pierre F RayGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France pray@chu-grenoble.fr.ORCID 0000-0003-1544-7449
Christophe ArnoultGenetic Epigenetic and Therapies of Infertility, Institute for Advanced Biosciences, Inserm U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
Centre National de la Recherche Scientifique · FRInserm · FRUniversité de Versailles Saint-Quentin-en-Yvelines · FRUniversity of Geneva · CHHôpital Nord · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azoospermia, characterized by the absence of spermatozoa in the ejaculate, is a common cause of male infertility with a poorly characterized etiology. Exome sequencing analysis of two azoospermic brothers allowed the identification of a homozygous splice mutation in

Indexed as

AnimalsAsthenozoospermiaAzoospermiaDisease Models, AnimalGlycoproteinsHeterozygoteHomozygoteMaleMiceMice, KnockoutSerine Peptidase Inhibitors, Kazal TypeGlycoproteinsSerine Peptidase Inhibitors, Kazal TypeSPINK2 protein, humanSPINK2 protein, mouseazoospermiaexome sequencinggeneticsinfertilityspermatogenesis

Identifiers

PMID28554943
PMCPMC5538632
OpenAlexW2617453476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.